Anemia Clinical Trial
Iron deficiency (ID) is still a main public health problem in sub-Saharan Africa. Iron
deficient children have an increased risk for anemia which is associated with adverse infant
development that might be partly irreversible. In sub-Saharan Africa, the etiology of ID in
children is multifactoral; but the major causes are low iron dietary bioavailability and
intake from monotonous cereal-based complementary foods. Children < 5 years old can benefit
from iron-fortified complementary foods; however, these fortified complementary foods are
often not adapted to the requirements of children in specific setting. The investigators
developed a complementary food fortificant (CFF) which is added to local porridge and is
deemed to meet the nutrient intake requirement for iron in children 1-3 years of age. The
CFF is lipid-based and can therefore, if regularly used, increase the daily energy intake of
children which is often too low in developing countries with cereal-based diets.
The iron absorption from the mixture of CFF and porridge has to be optimized because it
contains quite a high amount of phytate, a well-known inhibitor of iron absorption. To
optimize iron absorption the investigators are planning three iron absorption studies using
different compounds of iron (FeSO4 + NaFeEDTA), additional vitamin C and phytase, which is
able to degrade phytate. In the first study, iron absorption will be determined from a
mixture of CFF and porridge fortified with 1) 6 mg FeSO4 and 2) 6 mg FeSO4 plus additional
vitamin C. In the second study, the test meals will be fortified with 1) 6 mg FeSO4 and 2) a
mixture of 3 mg FeSO4 + 3 mg NaFeEDTA. In the third study, test meals will be fortified with
1) 6 mg FeSO4, 2) 6 mg FeSO4 plus phytase, and 3) 6 mg FeSO4 plus additional vitamin C and
phytase. Iron absorption will be determined by incorporation of labeled iron into
erythrocytes, 14 days after the administration of a test meal containing labeled iron
(stable isotope technique). Sixty apparently healthy Beninese children 12-36 months of age
with a body weight > 8.3 kg will be included in the study. Additionally, the investigators
will test acceptability of CFFs based on different composition formulas by interviewing the
parents/legal guardians of the children after feeding the CFF for a defined period.
The results of these studies will provide important insights to optimize the iron absorption
of young children from a CFF mixed with local traditional porridge in developing countries.
Furthermore the studies will provide information on the acceptability of CFFs in such a
setting.
n/a
Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00801931 -
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
|
Phase 1/Phase 2 | |
Completed |
NCT02948283 -
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
Completed |
NCT03341338 -
Genes-in-Action - Hepcidin Regulation of Iron Supplementation
|
||
Completed |
NCT00060398 -
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
|
Phase 3 | |
Recruiting |
NCT05384691 -
Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions
|
Phase 2 | |
Not yet recruiting |
NCT06309641 -
Methemoglobinemia Following Intravenous Iron Treatment
|
||
Completed |
NCT02930850 -
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
|
N/A | |
Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
Completed |
NCT02912533 -
A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT03822884 -
Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02912494 -
A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT02384122 -
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
|
Phase 3 | |
Completed |
NCT02603250 -
Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda
|
N/A | |
Completed |
NCT02176759 -
Iron Absorption From Rice Fortified With Ferric Pyrophosphate
|
N/A | |
Completed |
NCT01922479 -
Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure
|
Phase 4 | |
Completed |
NCT02310113 -
Transfusion and Skeletal Muscle Tissue Oxygenation
|
N/A | |
Withdrawn |
NCT01934842 -
A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate
|
N/A | |
Completed |
NCT01693029 -
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
|
Phase 3 | |
Completed |
NCT01458028 -
Age and Gender Effects on the Pharmacokinetics of BAY85-3934
|
Phase 1 | |
Terminated |
NCT01535781 -
Study of the Effect of Tranexamic Acid Administered to Patients With Hip Fractures. Can Blood Loss be Reduced?
|
N/A |